Highest-materiality recent filing
HCSG Q2 2026: Revenue $470.8M, EPS $0.32, reaffirms mid-single-digit growth outlook
Revenue of $470.8M; Environmental segment $213.2M (13.3% margin), Dietary $257.6M (7.5% margin).
HCSG annual meeting: all four proposals approved, 2.5M share increase for equity plan
All nine director nominees elected; highest votes 62.1M for Thomas M. Gallagher, lowest 60.6M for Diane S. Casey.
HCSG Q1 revenue $462.8M (+3.4%), EPS $0.37, reiterates 2026 mid-single-digit growth outlook
Revenue $462.8M, up 3.4% YoY; diluted EPS $0.37; net income $26.1M.
HCSG amends credit agreement, extends revolving credit facility maturity to April 7, 2031
Extended maturity date of $300M revolving credit facility to April 7, 2031 from prior maturity.
HCSG reports Q4 EPS $0.44, FY revenue $1.84B; announces $75M buyback
Q4 EPS $0.44, net income $31.2M; FY EPS $0.81, net income $59.1M.
HCSG beats Q3 expectations with 8.5% revenue growth; EPS of $0.59 includes $0.36 ERC benefit
Q3 revenue $464.3M (+8.5% YoY); net income $43.0M, diluted EPS $0.59 including $0.36 ERC benefit.
HCSG Q2 revenue up 7.6% to $458.5M; net loss $0.44/diluted share on $0.65 Genesis charge
Revenue $458.5M (+7.6% YoY); mid-single-digit growth guidance reaffirmed for 2025.
HCSG reports ~$0.62/share Q2 charge from client Genesis bankruptcy; reaffirms 2025 guidance
Genesis HealthCare filed Chapter 11 on July 9; HCSG provides services to 164 Genesis facilities.
HCSG annual meeting: all 9 director nominees elected, say on pay and auditor ratification approved
All nine director nominees elected with votes for ranging from ~63.4M to ~65.1M shares.
HCSG reports Q1 revenue $447.7M (+5.7% YoY), EPS $0.23; raises FY 2025 cash flow forecast to $60-75M
Revenue $447.7M (+5.7% YoY); diluted EPS $0.23; net income $17.2M.
HCSG reports Q4 revenue $437.8M, diluted EPS $0.16; guides Q1 2025 revenue $440-450M
Revenue $437.8M, net income $11.9M ($0.16 diluted EPS) inclusive of start-up costs.
Healthcare Services Group Q3 revenue $428.1M, in line; EPS $0.19; reaffirms Q4 guidance
Revenue $428.1M meets guidance; Q4 revenue estimate reaffirmed at $430-440M.
Healthcare Services Group reports cybersecurity incident; no expected material impact
Unauthorized activity discovered Oct 9, 2024; activated Cybersecurity Incident Response Process with third-party experts.
Healthcare Services Group appoints Vikas Singh as EVP & CFO effective Sept 3, 2024
Vikas Singh appointed EVP & CFO, effective September 3, 2024, overseeing accounting, finance, corporate development, and IR.
HCSG Q2 net loss $1.8M on $426.3M revenue; raises H2 revenue estimates
Net loss $1.8M, diluted EPS -$0.02; includes $0.22/share charge from LaVie Chapter 11 restructuring.
HCSG estimates $0.20 Q2 charge from LaVie Chapter 11; reiterates 2024 cash flow
Q2 non-cash charge of ~$0.20 per share due to LaVie Care Centers Chapter 11 filing.
HCSG shareholders approve all four proposals at 2024 annual meeting
Nine director nominees elected; highest votes for Wahl and Ottaviano (lowest).
Diluted EPS of $0.21 (adjusted $0.22) exceeds expectations; net income $15.3M.
HCSG Q4 2023: adjusted EPS $0.20, revenue $423.8M, cash flow beats guidance
Net income $22.6M ($0.31 diluted EPS); adjusted net income $14.6M ($0.20 adjusted EPS).
HCSG Q3 GAAP loss $0.07/share; adjusted EPS $0.17 (up 13.3%); raises H2 cash flow guidance
Revenue $411.4M, adjusted revenue $424.0M in line with $420-430M range; Q4 revenue guided at $420-430M.
HCSG Q2 2023 revenue $418.9M, net income $8.6M, adjusted EBITDA $26.3M
Revenue $418.9M; housekeeping & laundry $190.8M (8.7% margin), dining & nutrition $228.1M (5.5% margin).
HCSG shareholders elect all nine directors, approve 2.5M share plan increase
All nine director nominees elected; leading vote-getter Daniela Castagnino with 63.9M votes for.
HCSG Q1 revenue $417.2M, adjusted EBITDA up 18% to $27.5M
GAAP net income $12.7M ($0.17 per share); adjusted EBITDA $27.5M, up 18% YoY.
HCSG holds Q4 2022 earnings call; financial details not extractable from filed transcript excerpt
Conference call held on Feb 15, 2023 to discuss Q4 2022 financial results.
Revenue $424.0M; net income $16.2M ($0.22 EPS); direct cost target of 86.5% achieved.
HCSG renews credit facility: $300M unsecured revolver due 2027, down from $475M
New $300M unsecured revolving credit facility matures Nov 22, 2027; can be increased to $500M.
HCSG Q3 revenue $414.5M, net income $0.3M; cost of services 90.9%
Net income of $0.3M; cost of services 90.9% impacted by $7.6M AR reserve increase.
Revenue $424.9M; housekeeping & laundry $199.1M, dining & nutrition $225.8M; segment margins 9.0% and 4.5%.
HCSG reports Q2 2022 results via conference call; transcript missing detailed figures
Filed earnings call transcript for quarter ended June 30, 2022 on July 20, 2022.
Company settles four derivative actions without admitting fault or wrongdoing.
Healthcare Services Group annual meeting elects 9 directors, ratifies auditor, approves say-on-pay
All 9 director nominees elected; top vote-getter Kurt Simmons Jr. with 63.9M for, 0.57M withheld.
HCSG Q1 2022 revenue $426.8M, net income $11.3M ($0.15 EPS); declares $0.2125 dividend
Revenue $426.8M (housekeeping/laundry $201.7M, dining/nutrition $225.1M).
HCSG Q4 revenue $420.4M, EPS $0.03; margins pressured by labor inflation
Revenue $420.4M; net income $2.1M ($0.03 EPS); housekeeping & laundry $200.0M, dining $220.4M.
HCSG Q3 revenue $415.6M, net income $9.5M ($0.13 EPS); cites labor inflation, Delta surge headwinds
Revenue $415.6M, net income $9.5M ($0.13 diluted EPS); direct costs 87.8% of revenue.
Healthcare Services Group settles SEC EPS probe for $6M; CFO Shea shifts to CAO role
Agreed to pay $6.0M civil penalty to SEC for EPS calculation errors from 2014-2017; neither admitted nor denied charges.
HCSG Q2 revenue $398.2M, EPS $0.13; $6M SEC reserve, $3M labor reserve, Genesis adjustment
Revenue $398.2M, net income $9.6M, diluted EPS $0.13; cash flow from operations $25.3M.
On September 3, 2024 , the Board of Directors of Healthcare Services Group, Inc. (“HCSG” or the “Company”) approved the appointment of Vikas Singh as the Company’s Executive Vice President and Chief Financial Officer, effective the same day.
On October 19, 2021, the Board of Directors (the "Board") of the Company appointed Kurt Simmons, Jr. as a member of the Board, effective November 1, 2021.
John C. Shea, who had served as the Company’s Chief Financial Officer since 2012, has been appointed Chief Administrative Officer and will transition to that role effective September 1, 2021.
Max materiality 0.80 · Median 0.65 · Most common event earnings